First Trust Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74.2M Buy
630,070
+347,294
+123% +$48.5M 0.05% 437
2025
Q4
$46.3M Buy
282,776
+16,486
+6% +$2.58M 0.03% 590
2025
Q3
$35.6M Buy
266,290
+4,707
+2% +$572K 0.03% 711
2025
Q2
$32.5M Buy
261,583
+9,473
+4% +$1.21M 0.03% 746
2025
Q1
$32.1M Sell
252,110
-33,451
-12% -$5.15M 0.03% 711
2024
Q4
$41.1M Sell
285,561
-15,023
-5% -$2.15M 0.04% 614
2024
Q3
$44.7M Buy
300,584
+91,695
+44% +$13.1M 0.04% 542
2024
Q2
$26.3M Sell
208,889
-45,508
-18% -$7.13M 0.03% 686
2024
Q1
$46.8M Buy
254,397
+222,379
+695% +$42.4M 0.05% 495
2023
Q4
$5.76M Sell
32,018
-8,782
-22% -$1.37M 0.01% 1183
2023
Q3
$6.49M Buy
40,800
+3,985
+11% +$651K 0.01% 1122
2023
Q2
$5.21M Sell
36,815
-3,383
-8% -$542K 0.01% 1213
2023
Q1
$6.77M Sell
40,198
-94,993
-70% -$16.9M 0.01% 1103
2022
Q4
$22.9M Buy
135,191
+89,724
+197% +$16.3M 0.03% 661
2022
Q3
$8.51M Buy
+45,467
New +$9.59M 0.01% 997
2022
Q2
Sell
-86,120
Closed -$16.2M 2585
2022
Q1
$16.2M Sell
86,120
-49,004
-36% -$9.31M 0.02% 883
2021
Q4
$35.8M Buy
135,124
+85,857
+174% +$23.1M 0.03% 597
2021
Q3
$14.2M Sell
49,267
-47,199
-49% -$12.1M 0.02% 895
2021
Q2
$19.3M Sell
96,466
-44,324
-31% -$8.6M 0.02% 794
2021
Q1
$27.4M Sell
140,790
-27,167
-16% -$5.57M 0.03% 603
2020
Q4
$32.2M Sell
167,957
-18,872
-10% -$3.43M 0.04% 501
2020
Q3
$27.6M Buy
186,829
+148,657
+389% +$21.2M 0.04% 456
2020
Q2
$4.72M Sell
38,172
-3,601
-9% -$424K 0.01% 1005
2020
Q1
$4.03M Sell
41,773
-9,697
-19% -$936K 0.01% 952
2019
Q4
$4.76M Buy
51,470
+7,787
+18% +$654K 0.01% 1123
2019
Q3
$3.35M Sell
43,683
-10,195
-19% -$892K 0.01% 1253
2019
Q2
$4.63M Sell
53,878
-14,053
-21% -$958K 0.01% 1100
2019
Q1
$4.01M Sell
67,931
-1,672
-2% -$96.2K 0.01% 1146
2018
Q4
$3.67M Buy
69,603
+422
+0.6% +$24.7K 0.01% 1128
2018
Q3
$3.84M Buy
+69,181
New +$3.57M 0.01% 1292
2018
Q1
Sell
-14,782
Closed -$536K 2368
2017
Q4
$536K Sell
14,782
-32,128
-68% -$1.16M ﹤0.01% 2066
2017
Q3
$1.8M Buy
46,910
+7,874
+20% +$330K ﹤0.01% 1537
2017
Q2
$1.62M Buy
39,036
+17,996
+86% +$684K ﹤0.01% 1621
2017
Q1
$741K Sell
21,040
-7,838
-27% -$248K ﹤0.01% 1948
2016
Q4
$890K Buy
28,878
+8,945
+45% +$277K ﹤0.01% 1890
2016
Q3
$602K Buy
19,933
+524
+3% +$15.8K ﹤0.01% 1931
2016
Q2
$531K Sell
19,409
-2,771
-12% -$70.9K ﹤0.01% 1939
2016
Q1
$595K Buy
22,180
+9,875
+80% +$242K ﹤0.01% 1871
2015
Q4
$348K Sell
12,305
-42,448
-78% -$1.22M ﹤0.01% 2048
2015
Q3
$1.52M Buy
54,753
+2,410
+5% +$87.1K ﹤0.01% 1535
2015
Q2
$2.16M Buy
52,343
+45,560
+672% +$1.67M 0.01% 1484
2015
Q1
$206K Sell
6,783
-18,331
-73% -$475K ﹤0.01% 2152
2014
Q4
$497K Sell
25,114
-65,476
-72% -$1.46M ﹤0.01% 1981
2014
Q3
$1.8M Buy
+90,590
New +$1.91M 0.01% 1444

Other funds holding RGEN

First Trust Advisors's RGEN Position: Q1 2026 in Review

First Trust Advisors increased its Repligen (RGEN) stake by 123% in Q1 2026, buying an estimated $48.5M and bringing the position to 630,070 shares worth $74.2M. The position accounts for 0.05% of the portfolio, ranked #437.

First Trust Advisors first reported a position in RGEN in Q3 2014 and has held it in 44 quarters since. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • First Trust Advisors held 630,070 shares of Repligen worth $74.2M as of Q1 2026.
  • First Trust Advisors bought 347,294 Repligen shares in Q1 2026, an estimated $48.5M.
  • Repligen made up 0.05% of First Trust Advisors's portfolio in Q1 2026, its #437 holding.
  • First Trust Advisors first reported a position in Repligen in Q3 2014 and has held it in 44 quarters since.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.